3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 1 0 0 0 0 0999 V2000
0.0000 0.0000 -0.2140 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0914 1.0308 -0.1173 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0914 -1.0308 -0.1173 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.0368 0.4145 0.8240 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0368 -0.4144 0.8239 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0232 -0.5744 0.5824 C 0 0 1 0 0 0 0 0 0 0 0 0
1.0232 0.5744 0.5824 C 0 0 1 0 0 0 0 0 0 0 0 0
-1.7665 -1.6543 -0.1837 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7666 1.6542 -0.1837 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8375 -0.8778 -0.9496 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8375 0.8779 -0.9496 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1143 0.3017 -0.0488 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1142 -0.3016 -0.0487 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6410 -0.9663 1.5321 H 0 0 0 0 0 0 0 0 0 0 0 0
0.6410 0.9663 1.5321 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.2578 -2.3412 0.5164 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.1252 -2.2343 -0.8536 H 0 0 0 0 0 0 0 0 0 0 0 0
2.2580 2.3411 0.5166 H 0 0 0 0 0 0 0 0 0 0 0 0
1.1253 2.2345 -0.8535 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.7394 -1.4748 -1.1044 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.4588 -0.5097 -1.9081 H 0 0 0 0 0 0 0 0 0 0 0 0
3.7394 1.4748 -1.1044 H 0 0 0 0 0 0 0 0 0 0 0 0
2.4588 0.5097 -1.9081 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.9546 1.1508 1.5176 H 0 0 0 0 0 0 0 0 0 0 0 0
1.9546 -1.1508 1.5176 H 0 0 0 0 0 0 0 0 0 0 0 0
1 6 1 0 0 0 0
1 7 1 0 0 0 0
2 12 2 0 0 0 0
3 13 2 0 0 0 0
4 6 1 0 0 0 0
4 12 1 0 0 0 0
4 24 1 0 0 0 0
5 7 1 0 0 0 0
5 13 1 0 0 0 0
5 25 1 0 0 0 0
6 8 1 0 0 0 0
6 14 1 0 0 0 0
7 9 1 0 0 0 0
7 15 1 0 0 0 0
8 10 1 0 0 0 0
8 16 1 0 0 0 0
8 17 1 0 0 0 0
9 11 1 0 0 0 0
9 18 1 0 0 0 0
9 19 1 0 0 0 0
10 12 1 0 0 0 0
10 20 1 0 0 0 0
10 21 1 0 0 0 0
11 13 1 0 0 0 0
11 22 1 0 0 0 0
11 23 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
5-(5-oxopyrrolidin-2-yl)oxypyrrolidin-2-one
4.2 InChl
InChI=1S/C8H12N2O3/c11-5-1-3-7(9-5)13-8-4-2-6(12)10-8/h7-8H,1-4H2,(H,9,11)(H,10,12)
4.3 InChlKey
PGESPRACEXOTIG-UHFFFAOYSA-N
4.4 Canonical SMILES
C1CC(=O)NC1OC2CCC(=O)N2
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病